Efficacy of Traditional Chinese Medicine Patch Application at the Shenque (RN8) Acupoint in Cancer Patients Scheduled to Undergo Radiotherapy: A Study on Cancer-Related Fatigue and Heart Rate Variability
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
This randomized, double-blind, parallel-group controlled clinical trial aims to evaluate the effects of traditional Chinese medicine patch application at the Shenque (RN8) acupoint on cancer-related fatigue in adult cancer patients scheduled to undergo radiotherapy. Eligible participants will be randomly assigned to receive either a traditional Chinese medicine patch or a sham patch at the same acupoint. The intervention will be applied once daily for 2 hours, 7 days per week, for 2 consecutive weeks, for a total of 14 sessions. Fatigue severity, quality of life, heart rate variability, complete blood count, and skin safety will be assessed before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2026
CompletedFirst Posted
Study publicly available on registry
July 8, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
July 24, 2026
July 1, 2026
12 months
July 2, 2026
July 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Fatigue Severity Assessed by Visual Analog Scale From Baseline to End of Intervention
Baseline and approximately 2 weeks
Secondary Outcomes (4)
Change in Quality of Life Assessed by Functional Assessment of Cancer Therapy-General From Baseline to End of Intervention
Baseline and approximately 2 weeks
Change in Heart Rate Variability From Baseline to End of Intervention
Baseline and approximately 2 weeks
Change in Complete Blood Count Parameters From Baseline to End of Intervention
Baseline and approximately 2 weeks
Incidence of Skin Reactions at the Patch Application Site
During the 2-week intervention
Study Arms (2)
Traditional Chinese Medicine Patch
EXPERIMENTALParticipants in this arm will receive traditional Chinese medicine patch application at the Shenque (RN8) acupoint once daily for 2 hours, 7 days per week, for 2 consecutive weeks, for a total of 14 sessions.
Sham Patch
SHAM COMPARATORParticipants in this arm will receive a sham patch at the Shenque (RN8) acupoint using the same frequency and duration as the experimental group. The sham patch will be made with flour and caramel coloring instead of traditional Chinese medicine powder.
Interventions
The sham patch will be applied at the Shenque (RN8) acupoint using the same frequency and duration as the experimental intervention. The sham patch will be made with 5 g of flour and caramel coloring instead of traditional Chinese medicine powder.
The traditional Chinese medicine patch will be applied at the Shenque (RN8) acupoint once daily for 2 hours, 7 days per week, for 2 consecutive weeks, for a total of 14 sessions. The patch will be prepared by mixing 5 g of traditional Chinese medicine powder with 7 g of water and applying the mixture to gauze or a patch.
Eligibility Criteria
You may qualify if:
- Adults aged 20 years or older.
- Patients diagnosed with cancer by a physician.
- Patients scheduled to undergo radiotherapy.
- Patients who meet the diagnostic criteria for cancer-related fatigue and have a fatigue scale score of 4 or higher.
- Patients who are willing and able to provide written informed consent after receiving an explanation of the study procedures and possible risks.
You may not qualify if:
- Patients who are not suitable for traditional Chinese medicine patch application, including those with wounds or skin lesions at the acupoint application site.
- Patients who are unwilling to sign the informed consent form.
- Minors, pregnant women, patients with psychiatric disorders, or vulnerable populations.
- Patients with diseases that may affect heart rate variability.
- Patients who have received astragalus polysaccharide injection within 1 month before the start of the study.
- Patients who have used Chinese herbal medicine within 1 month before the start of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2026
First Posted
July 8, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
July 31, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
July 24, 2026
Record last verified: 2026-07